OSCR

The suppressor of cytokine signaling 3 regulates glioma stem cell maintenance and immune microenvironment through signal transducer and activator of transcription 3 signaling.

Overview

Authors: Jingtao Wang1, Gaolei Hou1, Zhaofei Song1, Kai Gao1, Hongbin Wang1, Tao Li1
ORCID iDs: Gaolei Hou, Tao Li
  1. The Fourth Department of Neurosurgery, Affiliated Hospital of Hebei Engineering University, Handan, China
Institutions: Hebei University of Engineering (China)
Journal: Journal of cell communication and signaling, volume 20, issue 3, article e70041
Dates: received 25 April 2025; accepted 14 August 2025; published online 1 August 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1002/ccs3.70041 · PMID 42542877 · PMCID PMC13428608 · OpenAlex W7172144024
Open access: hybrid, a free copy (OpenAlex)
Status: data only
Categories: genetics / omics (modality), other condition (population), cellular / molecular (subfield)
Methods: Statistics, Smoothing, state filtering, decompositions
Keywords: apoptosis resistance, glioma stem cells, scRNA‐seq, SOCS3, STAT3 signaling, tumor microenvironment
Topic: Cytokine Signaling Pathways and Interactions (Oncology, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 54 references in the paper

Abstract

This study aims to elucidate the role of suppressor of cytokine signaling 3 (SOCS3) in glioma stem cells (GSCs) via single‐cell RNA sequencing (scRNA‐seq), focusing on its regulation of STAT3‐mediated self‐renewal, apoptosis resistance, and tumor microenvironment (TME) remodeling. ScRNA‐seq data from 19 high‐grade glioma patients were analyzed using Seurat, Harmony, and SingleR for clustering, annotation, and SOCS3 stratification (SOCS3‐High: n = 4; SOCS3‐Low: n = 15). Differential gene analysis, pathway enrichment, and CellChat were employed for TME characterization. In vitro, SOCS3‐overexpressing/silenced GSC11 models were tested via MTT, TUNEL, neurosphere assays, and STAT3 pathway modulation (IL‐6). In vivo, intracranial xenografts in nude mice evaluated tumor growth and survival. SOCS3 was downregulated in GSCs and neurons. SOCS3‐Low GSCs exhibited 777 differentially expressed genes enriched in T‐cell receptor, p53, and JAK‐STAT axis, suppressed T‐cell/microglia infiltration, and promoted oligodendrocyte precursor cell/astrocyte survival. SOCS3 overexpression reduced GSC proliferation, induced apoptosis, inhibited neurosphere formation, and suppressed STAT3 phosphorylation and stemness markers (OCT4/SOX2/NANOG). IL‐6 reactivated STAT3, reversing SOCS3‐mediated tumor suppression. In vivo, SOCS3 overexpression attenuated tumor growth and prolonged survival, counteracted by IL‐6. Low SOCS3 expression contributes to glioma progression by promoting STAT3 activation and an immunosuppressive TME. Targeting the SOCS3‐STAT3 axis may offer therapeutic potential.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

All data can be provided as needed.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 6 authors, 6 keywords, 54 references.

Cite

This paper

Wang, J., Hou, G., Song, Z., Gao, K., Wang, H., & Li, T. (2026). The suppressor of cytokine signaling 3 regulates glioma stem cell maintenance and immune microenvironment through signal transducer and activator of transcription 3 signaling. Journal of cell communication and signaling, 20(3), e70041. https://doi.org/10.1002/ccs3.70041

BibTeX

@article{wang2026suppressor,
author = {Wang, Jingtao and Hou, Gaolei and Song, Zhaofei and Gao, Kai and Wang, Hongbin and Li, Tao},
title = {{The suppressor of cytokine signaling 3 regulates glioma stem cell maintenance and immune microenvironment through signal transducer and activator of transcription 3 signaling}},
journal = {Journal of cell communication and signaling},
year = {2026},
month = aug,
volume = {20},
number = {3},
pages = {e70041},
publisher = {Wiley},
issn = {1873-9601},
doi = {10.1002/ccs3.70041},
url = {https://doi.org/10.1002/ccs3.70041},
pmid = {42542877},
pmcid = {PMC13428608}
}

RIS

TY - JOUR
AU - Wang, Jingtao
AU - Hou, Gaolei
AU - Song, Zhaofei
AU - Gao, Kai
AU - Wang, Hongbin
AU - Li, Tao
TI - The suppressor of cytokine signaling 3 regulates glioma stem cell maintenance and immune microenvironment through signal transducer and activator of transcription 3 signaling
T2 - Journal of cell communication and signaling
J2 - J Cell Commun Signal
PY - 2026
DA - 2026/08/01
VL - 20
IS - 3
SP - e70041
SN - 1873-9601
PB - Wiley
DO - 10.1002/ccs3.70041
UR - https://doi.org/10.1002/ccs3.70041
LA - en
ER -

CSL-JSON

{
"id": "10.1002/ccs3.70041",
"type": "article-journal",
"title": "The suppressor of cytokine signaling 3 regulates glioma stem cell maintenance and immune microenvironment through signal transducer and activator of transcription 3 signaling",
"container-title": "Journal of cell communication and signaling",
"author": [
{
"family": "Wang",
"given": "Jingtao"
},
{
"family": "Hou",
"given": "Gaolei"
},
{
"family": "Song",
"given": "Zhaofei"
},
{
"family": "Gao",
"given": "Kai"
},
{
"family": "Wang",
"given": "Hongbin"
},
{
"family": "Li",
"given": "Tao"
}
],
"container-title-short": "J Cell Commun Signal",
"volume": "20",
"issue": "3",
"page": "e70041",
"DOI": "10.1002/ccs3.70041",
"PMID": "42542877",
"PMCID": "PMC13428608",
"ISSN": "1873-9601",
"publisher": "Wiley",
"URL": "https://doi.org/10.1002/ccs3.70041",
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1016/j.jbc.2026.113447
TIMELESS promotes glioma stemness and malignancy through JAK-STAT3 pathway.
Journal: The Journal of biological chemistry
In common: other condition, cellular / molecular, 1 reference
[2] doi:10.1038/s41598-026-53415-5 [code]
Computational design and immunoinformatics validation of a T cell multi-epitope vaccine targeting glioblastoma stem cells.
Journal: Scientific reports
In common: other condition, cellular / molecular, 1 reference
[3] doi:10.1002/advs.77551
Targeting the KAT7/H3K14ac/RAC2 Axis Mediates OXPHOS to Promote Stemness Maintenance and Malignancy in Glioblastoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
In common: other condition, 1 reference
[4] doi:10.1002/advs.77175
TAB2 Causes Neuronal Damage by Aggravating Microglia-Mediated Neuroinflammation in Parkinson's Disease.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
In common: cellular / molecular, 1 reference
[5] doi:10.1016/j.xcrm.2026.102937
A biomimetic hybrid membrane vesicle nanoplatform attenuates tendinopathy through neuroinflammation modulation and tendon regeneration.
Journal: Cell reports. Medicine
In common: cellular / molecular, 1 reference
[6] doi:10.1172/jci.insight.198298
Development and characterization of triazole-based WDR5 inhibitors for the treatment of glioblastoma.
Journal: JCI insight
In common: other condition, 1 reference
[7] doi:10.1038/s41467-026-71021-x
Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs.
Journal: Nature communications
In common: other condition, 1 reference
[8] doi:10.3390/life16081245
Growth Hormone-Insulin-like Growth Factor Axis and GDF-15 in Critical Illness: Implications for Survival Stratification.
Journal: Life (Basel, Switzerland)
In common: 1 reference
[9] doi:10.3390/biomedicines14040859
Current Perspectives on the Inflammatory Bowel Disease Pathogenesis of Microbiota and the Gut-Brain Axis, and Emerging Therapeutics.
Journal: Biomedicines
In common: 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.